+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vancomycin"

MRSA Antibiotics Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, and Product Type - Product Thumbnail Image

MRSA Antibiotics Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, and Product Type

  • Report
  • January 2024
  • 73 Pages
  • Global
From
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 44 Pages
  • Global
From
Vancomycin-Resistant Enterococcus Faecium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Vancomycin-Resistant Enterococcus Faecium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 78 Pages
  • Global
From
21st Century Challenges in Antimicrobial Therapy and Stewardship - Product Thumbnail Image

21st Century Challenges in Antimicrobial Therapy and Stewardship

  • Book
  • November 2020
From
2024-2028 Global Vancomycin-Resistant Enterococcus (VRE) Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Thumbnail Image

2024-2028 Global Vancomycin-Resistant Enterococcus (VRE) Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • October 2024
  • Global
From
2024-2028 Global Vancomycin Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Thumbnail Image

2024-2028 Global Vancomycin Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • October 2024
  • Global
From
2022-2026 Global Vancomycin-Resistant Enterococcus (VRE) Testing in 90 Countries - Product Thumbnail Image

2022-2026 Global Vancomycin-Resistant Enterococcus (VRE) Testing in 90 Countries

  • Report
  • December 2021
  • Global
From
Antibiotic Drug Resistance. Edition No. 1 - Product Thumbnail Image

Antibiotic Drug Resistance. Edition No. 1

  • Book
  • October 2019
  • 720 Pages
Loading Indicator

Vancomycin is an antibiotic used to treat a wide range of bacterial infections. It is a glycopeptide antibiotic, derived from the bacterium Amycolatopsis orientalis, and is used to treat infections caused by Gram-positive bacteria. Vancomycin is often used as a last-resort antibiotic, when other antibiotics have failed to treat an infection. It is also used to treat infections caused by Clostridium difficile, a bacterium that can cause severe diarrhea. Vancomycin is available in both oral and intravenous forms, and is used to treat a variety of infections, including skin and soft tissue infections, bone and joint infections, and endocarditis. It is also used to treat infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Vancomycin is a widely used antibiotic, and is available from a number of pharmaceutical companies, including Pfizer, Merck, and AstraZeneca. It is also available in generic form from a number of generic drug manufacturers. Show Less Read more